购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

Y06036

产品编号 T5362Cas号 1832671-96-1
别名

Y06036 是一种选择性 BET 抑制剂,具有抗肿瘤活性,可与 BRD4(1)溴结构域结合,Kd 值为 82 nM。

Y06036
TargetMol

为众多的药物研发团队赋能,

让新药发现更简单!

Y06036

产品编号 T5362Cas号 1832671-96-1

Y06036 是一种选择性 BET 抑制剂,具有抗肿瘤活性,可与 BRD4(1)溴结构域结合,Kd 值为 82 nM。

规格价格库存数量
1 mg¥ 113现货
5 mg¥ 239现货
10 mg¥ 398现货
25 mg¥ 690现货
50 mg¥ 1,090现货
100 mg¥ 1,790现货
200 mg¥ 2,590现货
1 mL x 10 mM (in DMSO)¥ 273现货
大包装 & 定制
加入购物车
实验操作小课堂
查看更多

"Y06036"的相关化合物库

选择批次:
纯度:98.95%
联系我们获取更多批次信息
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品介绍

生物活性
产品描述
Y06036, a potent and selective BET inhibitor, can bind to the BRD4(1) bromodomain (Kd: 82 nM).
靶点活性
BRD4(1):82 nM (Kd, cell free)
体外活性
Y06036与BRD4(1)溴结构域结合,其Kd值为82 nM。Y06036在前列腺癌细胞系中强效抑制细胞增长、集落形成以及AR、AR调控基因和MYC的表达。
体内活性
小鼠在肿瘤体积达到约100 mm3时,随机分组并通过腹膜内(i.p.)给药,接受安慰剂或BET抑制剂Y06036(50 mg/kg,每周5次)治疗。在25天的治疗期间,Y06036表现出强大的抗肿瘤活性,肿瘤生长抑制(TGI)达到70%。
细胞实验
LNCaP, C4-2B, 22Rv1, and VCaP prostate cancer cells were cultured in RPMI 1640 with 10% FBS at 37 °C and an atmosphere of 5% CO2. For cell viability, cells were seeded in 384-well plates at 500?1000 cells per well (optimum density for growth) in a total volume of 20 μL of media. After 12 h, 10 μL of chemical compounds with 2-fold or 3-fold serial dilution was added to each well with final concentration from 5 nM to 100 μM. The measurement was conducted 96 h after seeded for LNCaP, C4-2B, and 22Rv1 and 144 h after seeded for VCaP. Then, 25 μL of CellTiter-GLO reagents was added, and luminescence was measured on GLOMAX microplate luminometer, according to the manufacturer's instructions. The estimated in vitro half-maximal inhibitory concentration (IC50) values were calculated using Prism 6 software.
动物实验
Four-week-old male mice (strain: C.B-17/IcrHsd-Prkdcscid for C4-2B) were used for tumor inoculation. Each mouse was inoculated subcutaneously at the dorsal flank on both sides of the mice with C4-2B tumor cells (2 × 10^6 cells) in a mixture of 100 μL PBS and Matrigel (1:1). When the tumor volume reached approximately 100 mm3, the mice were randomized into groups (n = 5?7 per group) and then treated intraperitoneally (ip) with 100 μL of either vehicle or Y06036 and 7m (in a formulation of 15% Cremophor EL, Calbiochem, 82.5% PBS, and 2.5% DMSO) five times per week. The length (L) and width (W) of the tumor mass were monitored by calipers, and volume was expressed in mm3 calculated with the equation V = (π/6)(L × W2). Tumor growth inhibition (TGI) was calculated using the equation TGI = [1 ? (T ? T0)/(C ? C0)] × 100, wherein T and T0 are the mean tumor volumes on a specific experimental day and on the first day of treatment, respectively, for the test groups; and likewise C and C0 are the mean tumor volumes for the vehicle group.
化学信息
分子量427.27
分子式C16H15BrN2O5S
CAS No.1832671-96-1
储存&溶解度
存储Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度信息
DMSO: 100 mg/mL (234 mM)
溶液配制表
DMSO
1mg5mg10mg50mg
1 mM2.3404 mL11.7022 mL23.4044 mL117.0220 mL
5 mM0.4681 mL2.3404 mL4.6809 mL23.4044 mL
10 mM0.2340 mL1.1702 mL2.3404 mL11.7022 mL
20 mM0.1170 mL0.5851 mL1.1702 mL5.8511 mL
50 mM0.0468 mL0.2340 mL0.4681 mL2.3404 mL
100 mM0.0234 mL0.1170 mL0.2340 mL1.1702 mL

计算器

  • 摩尔浓度 计算器
  • 稀释 计算器
  • 配液 计算器
  • 分子量 计算器

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法:
TargetMol | Animal experiments比如您的给药剂量是 10 mg/kg ,每只动物体重 20 g ,给药体积 100 μLTargetMol | Animal experiments 一共给药动物 10 只 ,您使用的配方为 5% TargetMol | reagent DMSO+ 30%PEG300+ 5%Tween 80 + 60% ddH2O. 那么您的工作液浓度为 2 mg/mL
母液配置方法: 2 mg 药物溶于 50 μLDMSOTargetMol | reagent ( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:50μLDMSOTargetMol | reagent 母液,添加 300 μLPEG300TargetMol | reagent 混匀澄清,再加 50μLTween 80, 混匀澄清,再加 600μLddH2OTargetMol | reagent 混匀澄清

以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。

1 请输入动物实验的基本信息
mg/kg
g
μL
2 请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
%Tween 80
%ddH2O

剂量转换

对于不同动物的给药剂量换算,您也可以参考 更多

关键词

Related Tags: buy Y06036 | purchase Y06036 | Y06036 cost | order Y06036 | Y06036 chemical structure | Y06036 in vivo | Y06036 in vitro | Y06036 formula | Y06036 molecular weight